Table 2.
In-hospital outcomes according to different stages of AKI by the KDIGO in patients with COVID-19
| In-hospital outcome† | AKI (N = 194) | Stage 1 (N = 120) | Stage 2 (N = 35) | Stage 3 (N = 39) | p value* |
|---|---|---|---|---|---|
| Mortality | 77 (39.7) | 27 (22.5)** | 18 (51.4) | 32 (82.1)** | <0.001 |
| Severity | 151 (77.8) | 87 (72.5) | 29 (82.9) | 35 (89.7) | 0.058 |
| ARDS | 78 (40.4) | 39 (32.8)** | 15 (42.9) | 24 (61.5)** | 0.006 |
| Invasive ventilation | 54 (27.8) | 20 (16.7)** | 12 (34.3) | 22 (56.4)** | <0.001 |
| ACI | 61 (31.4) | 30 (25.0) | 15 (42.9) | 16 (41.0) | 0.048 |
| ALI | 29 (14.9) | 11 (9.2)** | 9 (25.7) | 9 (23.1) | 0.015 |
| Multiorgan damage | 109 (56.2) | 54 (45.0)** | 26 (74.3) | 29 (74.4) | <0.001 |
ACI, acute cardiac injury; AKI, acute kidney injury; ALI, acute liver injury; ARDS, acute respiratory distress syndrome.
†
Data are presented as number (%).
*
Statistically significant p values are bolded.
**
Statistically significant Bonferroni-adjusted p values (p < 0.0083).